Skip To Main Content

RespTalks

Underlying inflammation in patients with severe/ uncontrolled CRSwNP: from targeting type 2 pathophysiology to shared clinical decision-making

Join us for this enlightening discussion!

Tuesday, October 24th 2023
12:00-13:00 CET & 18:00-19:00 CET
(two identical live lectures with Q&A)

We look forward to seeing you at the next RespTalks webinar featuring Prof. Gevaert and Prof. Toppila-Salmi. They will be shedding light on the underlying inflammation in patients with severe and uncontrolled CRSwNP and how biologics can lead to clinically relevant improvements for these patients.

Sign up today!

Speakers

Professor Philippe Gevaert

Philippe Gevaert, MD, Ph.D., is full professor in Rhinology and Allergy at the Department of Otorhinolaryngology and Chairman medical education at the Ghent University, Belgium. Further, he is the scientific coordinator of the Allergy Network of the Ghent University Hospital. Since 1998 Philippe is active in the Upper Airway Research Laboratory at the University of Ghent. He is the past Chairman of the ENT section of the EAACI. Currently, his research is focused on local IgE, allergen specific immunotherapy and biologicals in allergic rhinitis and nasal polyps.

Philippe has conducted several academic and industry sponsored clinical trials with novel treatments in nasal polyps and allergic rhinitis and he has published over 200 peer-reviewed papers.

Professor Sanna Toppila-Salmi

Sanna Toppila-Salmi, MD, PhD, Adj. Prof. is a Senior Consultant Otorhinolaryngologist, Department Chief Physician and Director of Helsinki Airway Research Group at the Skin and Allergy Hospital of the Helsinki University Hospital & University of Helinski and Professor at the University of Eastern Finland. Her research group combines epidemiology, genomics, metabolomics and sequence analysis to identify the pathobiology of NERD, type 2 inflammation, CRSwNP, asthma and allergic diseases. Her lab works with human cohorts to identify risk factors, mechanisms, and potential therapies for these disorders using machinge learning data science, sequencing omics approaches and clinical trials.

Klicka här för Dupixent minimiinformation

This webinars are intended for healthcare professionals and is organized by Sanofi North Europe.

Mötet följer de regler som gäller enligt avtalet mellan LIF och Sveriges Kommuner och Regioner. Inbjudan har skickats till läkare och sköterskor inom respiratoriska sjukdomar och allergologi med kopia till huvudman. Deltagaren ansvarar för att arbetsgivarens godkännande för deltagandet är inhämtat.

Relaterade Artiklar
MAT-BE-2300782 v1.0-07/2023